Games Workshop dropped a whole bunch of brand new previews for The Emperor's Children who are making a glorious return to the Grimdark future of Warhammer 40,000. New and returning characters make an ...

What are the best Warhammer games? Games Workshop has a complicated history with licensing its tabletop worlds. There were some great Warhammer Fantasy strategy games back in the ’90s ...

So, after locking himself in a tower for a year, Corax decided that he’d rather lead an attack ... Adam covers all things Tabletop Gaming. Which includes Warhammer 40,000, Age of Sigmar, D&D, Board ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

This new take on Fulgrim joins the rest of his battle brothers and fellow Primarchs who are sowing discord and destruction throughout the galaxy. Magnus, Mortarion and Angron all have plastic kits ...

After a brief lull in the run up to Christmas, the Warhammer 40,000 release schedule will be back to its usual relentless pace in the new year. As 2024 ends, we’re recapping every new 40k kit and ...

Religion plays a massive role in the Warhammer 40k setting, with the church known as the Ecclesiarchy holding massive social influence and temporal power within the Imperium of Man. Where there’s ...

The Corvus Cabal worships the Great Gatherer by taking treasures from the victims of their ambushes and assassinations. They believe the Archaon is an avatar of their god and as such, seek to gain his ...

With the latest Total War Warhammer 3 DLC now out in the world, developer Creative Assembly is looking ahead to 2025. The new factions mark the end of a very up-and-down year for the strategy game ...

Corvus Pharmaceuticals' stock plummeted ~40% after Phase 1 data for soquelitinib in atopic dermatitis showed mixed results, raising concerns about its efficacy. Phase 1 data for soquelitinib in AD ...

Mizuho views the selloff yesterday in shares of Corvus Pharmaceuticals (CRVS) following the Phase 1 data for soquelitinib in atopic dermatitis as “way overdone.” Mizuho found the data ...